121 related articles for article (PubMed ID: 8045920)
1. Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.
Gebbia V; Valenza R; Testa A; Sciume C; Longo A; Cipolla C; Borsellino N; Leo P; Latteri M; Florena M
J Cancer Res Clin Oncol; 1994; 120(9):550-2. PubMed ID: 8045920
[TBL] [Abstract][Full Text] [Related]
2. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules.
Haim N; Tsalik M; Robinson E
Oncology; 1994; 51(1):102-7. PubMed ID: 8265093
[TBL] [Abstract][Full Text] [Related]
3. Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancer.
Scarpellini M; Tononi A; Pasquini E; Oliverio G; Fattori PP; Gianni L; Desiderio F; Nicolini M; Ravaioli A
J Chemother; 1994 Jun; 6(3):211-5. PubMed ID: 7983505
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
Clark JL; Küçük O; Neuberg DS; Benson AB; Taylor SG; Pandya KJ; Mansour EG; Douglass HO; Haller DG
Am J Clin Oncol; 1995 Aug; 18(4):318-24. PubMed ID: 7625373
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.
Içli F; Karaoguz H; Akbulut H; Dinçol D; Demirkazik A; Cay F
J Surg Oncol; 1997 Apr; 64(4):318-23. PubMed ID: 9142190
[TBL] [Abstract][Full Text] [Related]
6. Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction.
Bar Sela G; Tsalic M; Gaitini D; Steiner M; Haim N
J Chemother; 2002 Dec; 14(6):623-6. PubMed ID: 12583555
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
Matsumura T; Ohnoshi T; Ueoka H; Kiura K; Tabata M; Genba K; Chikamori M; Ikubo S; Matsuo K; Kimura I
Gan To Kagaku Ryoho; 1994 Feb; 21(2):261-4. PubMed ID: 8311499
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.
Wilke H; Preusser P; Fink U; Gunzer U; Meyer HJ; Meyer J; Siewert JR; Achterrath W; Lenaz L; Knipp H
J Clin Oncol; 1989 Sep; 7(9):1318-26. PubMed ID: 2769330
[TBL] [Abstract][Full Text] [Related]
9. Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
Lerner A; Gonin R; Steele GD; Mayer RJ
J Clin Oncol; 1992 Apr; 10(4):536-40. PubMed ID: 1548518
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK).
Roth AD; Herrmann R; Morant R; Borner MM; Honegger HP; Obrist R; Bacchi M; Lange J; Alberto P; Castiglione M
Eur J Cancer; 1998 Dec; 34(13):2126-8. PubMed ID: 10070322
[TBL] [Abstract][Full Text] [Related]
11. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
Sparano JA; Schwartz EL; Salva KM; Pizzillo MF; Wadler S; Wiernik PH
Am J Clin Oncol; 1990 Oct; 13(5):374-8. PubMed ID: 2220657
[TBL] [Abstract][Full Text] [Related]
13. Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group.
Bajetta E; Di Bartolomeo M; de Braud F; Bozzetti F; Bochicchio AM; Comella P; Fagnani D; Farina G; Ferroni C; Franchi R
Eur J Cancer; 1994; 30A(5):596-600. PubMed ID: 8080673
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].
Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2191-6. PubMed ID: 2241183
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
17. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
Wang X; Pang L; Feng J
Am J Clin Oncol; 2002 Feb; 25(1):71-5. PubMed ID: 11823701
[TBL] [Abstract][Full Text] [Related]
19. [Etoposide, doxorubicin, cisplatin and 5-FU (EAP-F) therapy of advanced gastric cancer--its antitumor effect and evaluation of quality of life].
Suda K; Kano Y; Inada T; Ogata Y
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1791-5. PubMed ID: 8379671
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial.
Kulig J; Kolodziejczyk P; Sierzega M; Bobrzynski L; Jedrys J; Popiela T; Dadan J; Drews M; Jeziorski A; Krawczyk M; Starzynska T; Wallner G
Oncology; 2010; 78(1):54-61. PubMed ID: 20215786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
